FINWIRES · TerminalLIVE
FINWIRES

$MIST

2 stories mentioning MISTUpdated 31d ago

Every FINWIRES story that references MIST, newest first.

What are analysts saying about MIST?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on MIST?

Research

Cantor Fitzgerald Initiates Milestone Pharmaceuticals at Overweight With $3 Price Target

Milestone Pharmaceuticals (MIST) has an average rating of buy and mean price target of $6.33, according to analysts polled by FactSet.

$MIST
Research

Raymond James Initiates Milestone Pharmaceuticals at Strong Buy

Milestone Pharmaceuticals (MIST) has an average rating of buy and mean price target of $6.50, according to analysts polled by FactSet.

$MIST

Track with the FINWIRES app suite

FolioX
FolioX
Track MIST in your portfolio
WheelAI
WheelAI
Analyze MIST options with the wheel strategy
StockInsider
StockInsider
See market sentiment on MIST